United Kingdom · Question · Written question
UIN 672
Abiraterone
Original
Introduced
8 November 2023
Last action
17 November 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
17 November 2023
Summary
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential impact of the level of availability of abiraterone on the NHS on the health of prostate cancer patients.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
8 November 2023
Written question
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential impact of the level of availability of abiraterone on the NHS on the health of prostate cancer patients.
Source: Commons
17 November 2023
Answer
The National Institute for Health and Care Excellence (NICE) is the independent body that provides evidence-based guidance for the National Health Service on whether new medicines represent a clinically- and cost-effective use of resources. The NHS is leg...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-11-08/672
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1668422
- uk · wq-1668422 · source updated 17 November 2023